Mawer Investment Management
CLBT icon

Mawer Investment Management’s Cellebrite CLBT Stock Holding History

Mawer Investment Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-323,310
Closed -$2.47M – 108
2023
Q3 		$2.47M Buy
323,310
+25,159
+8% +$189K 0.01% 93
2023
Q2 		$2.15M Buy
298,151
+23,920
+9% +$139K 0.01% 93
2023
Q1 		$1.67M Buy
274,231
+1,757
+0.6% +$9.52K 0.01% 97
2022
Q4 		$1.19M Sell
272,474
-46,467
-15% -$208K 0.01% 103
2022
Q3 		$1.25M Buy
318,941
+46,306
+17% +$232K 0.01% 95
2022
Q2 		$1.39M Buy
272,635
+63,888
+31% +$332K 0.01% 85
2022
Q1 		$1.34M Buy
208,747
+123,232
+144% +$817K 0.01% 89
2021
Q4 		$686K Buy
85,515
+63,120
+282% +$595K ﹤0.01% 106
2021
Q3 		$207K Buy
+22,395
New +$234K ﹤0.01% 108

Other funds holding CLBT

IIGPLP
IGP Investments (G.P.L.P.) Herzliya, Israel $6.25M AUM 18.64% 1-Year Est. Return
TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Mawer Investment Management's CLBT Position: Q4 2023 in Review

Mawer Investment Management sold out of Cellebrite (CLBT) in Q4 2023, closing a stake of 323,310 shares — an estimated $2.47M sold.

Mawer Investment Management first reported a position in CLBT in Q3 2021 and held it in 9 quarters. The position peaked at $2.47M in Q3 2023. 116 funds tracked by Wall St. Rank hold CLBT as of Q4 2023.

  • Mawer Investment Management reported no remaining Cellebrite position as of Q4 2023 after selling out during the quarter.
  • Mawer Investment Management sold 323,310 Cellebrite shares in Q4 2023, an estimated $2.47M.
  • Mawer Investment Management first reported a position in Cellebrite in Q3 2021 and held it in 9 quarters.
  • Mawer Investment Management's Cellebrite position peaked at $2.47M in Q3 2023.
  • 116 funds tracked by Wall St. Rank held Cellebrite as of Q4 2023.

Based on Mawer Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.